ArticleFrontiers in pharmacology2025
Hemodialysis-induced renal perfusion decline: unraveling the pathophysiological mechanisms linking intradialytic circulatory stress to residual renal function loss.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07003828 (Hemodialysis-Induced Renal Perfusion Decline), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Hemodialysis-Induced Renal Perfusion Decline: Unraveling the Pathophysiological Mechanisms Linking Intradialytic Circulatory Stress to Residual Renal Function Loss
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Residual renal function (RRF) plays a critical role in quality of life and survival in hemodialysis (HD) patients but characteristically declines after the initiation of HD. Owing to incomplete understanding of the pathophysiology underlying RRF decline, protective strategies remain limited. The aim of this study was to explore the dynamic changes of renal perfusion in incident HD patients with preserved RRF during dialysis sessions and to provide new strategies for RRF preservation. Methods: This prospective cohort study enrolled 30 incident HD patients with preserved RRF. Renal perfusion was serially assessed using contrast-enhanced ultrasonography (CEUS) at three time points during the HD session: pre-dialysis baseline, intradialytic phase (3 h post-initiation), and post-dialysis recovery phase (15 min after session completion). Renal perfusion was quantified using the CEUS-assessed perfusion index (PI). The primary outcome measure was the PI. Results: During hemodialysis sessions, the PI as a surrogate marker of renal perfusion decreased by 17.53% (P < 0.001), which exhibited a negative correlation with ultrafiltration (UF) rates (Spearman's r = -0.770, P < 0.001), but not with other variables such as sex, age, body mass index (BMI), blood pressure (BP), estimated glomerular filtration rate (eGFR), hemoglobin, or albumin levels. Conclusion: This study demonstrates that incident HD patients experience an acute decrease in renal perfusion during hemodialysis, which is negatively correlated with mean UF rates. This finding may represent a crucial step toward elucidating the pathophysiology of hemodialysis-mediated RRF decline. Clinical trial registration: clinicaltrials.gov, identifier (NCT07003828).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.